Kaseya Announces Industry-First MSP Insights Portal
Dec 13, 2017 12:00 pm UTC| Business
NEW YORK and MIAMI, Dec. 13, 2017 -- Kaseya®, the leading provider of complete IT management solutions for managed service providers (MSPs) and mid-market enterprises (MME), today announced the launch of MSP Insights, a...
Natus to Present at J.P. Morgan 36th Annual Healthcare Conference
Dec 13, 2017 12:00 pm UTC| Business
PLEASANTON, Calif., Dec. 13, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer will present and Jonathan Kennedy, Executive Vice President and Chief...
Q Therapeutics Announces Research Collaboration With REPROCELL
Dec 13, 2017 12:00 pm UTC| Business
SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury, announced a collaborative research agreement...
Financial Gravity Teams Up with SparkTen for Branding and Integration Services
Dec 13, 2017 12:00 pm UTC| Business
ALLEN, Texas, Dec. 13, 2017 -- Financial Gravity Tax, Inc., a subsidiary of Financial Gravity Companies, Inc. (OTCQB:FGCO), has contracted with SparkTen in Frisco, TX to assist with a rebranding and integration...
The Mansion on Main Street Welcomes a New Director of Sales
Dec 13, 2017 12:00 pm UTC| Business
VOORHEES, N.J., Dec. 13, 2017 -- The Mansion on Main Street, located in South New Jersey, happily welcomes Erin Crofchick to their award winning team as the new Director of Sales. Erin brings her outstanding leadership...
GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S.
Dec 13, 2017 12:00 pm UTC| Business
LONDON, Dec. 13, 2017 -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...
Iovance Biotherapeutics Expands Pipeline of TIL Therapies into Lung Cancer
Dec 13, 2017 12:00 pm UTC| Business
Moffitt Cancer Center Phase 1 Study Combining TIL and Nivolumab Initiated in NSCLC Patients Iovance/MedImmune Clinical Collaboration to Initiate with Start of Phase 2 Study in PD-1/PDL-1 Naïve NSCLC Patients...
FxWirePro- Major Economic Events for the day
FxWirePro- Major Economic Events for the day
Australia's Employment Growth Slows: Key Insights from October 2024
FxWirePro-Major Economic events today
HTX Cracks Down on Phishing and Theft: Over 280K Security Alerts Sent to Protect User Assets